Actavis

Actavis

Employees:
2,600
Market Cap:
$24.63 billion
Revenue:
$2.1 billion
5 Year Trend:
6.1%
Net Income:
$604.47 million

Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis, plc, prior to the acquisition of Allergan, inc) is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. Wikipedia

Actavis

Employees:
2,600
Market Cap:
$24.63 billion
Revenue:
$2.1 billion
5 Year Trend:
6.1%
Net Income:
$604.47 million

Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis, plc, prior to the acquisition of Allergan, inc) is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. Wikipedia